These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 2557650
1. The ACTH (4-9) analog ORG 2766 in panic disorder: a preliminary study. den Boer JA, Westenberg HG, Mastenbroek B, van Ree JM. Psychopharmacol Bull; 1989; 25(2):204-8. PubMed ID: 2557650 [No Abstract] [Full Text] [Related]
2. Lorazepam vs. alprazolam in the treatment of panic disorder. Schweizer E, Pohl R, Balon R, Fox I, Rickels K, Yeragani VK. Pharmacopsychiatry; 1990 Mar; 23(2):90-3. PubMed ID: 2187213 [Abstract] [Full Text] [Related]
3. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder. Westenberg HG, den Boer JA. Psychopharmacol Bull; 1989 Mar; 25(1):119-23. PubMed ID: 2528158 [No Abstract] [Full Text] [Related]
4. The MSH/ACTH analog ORG 2766 in anxiety disorders. Den Boer JA, Westenberg HG, De Vries H. Peptides; 1992 Mar; 13(1):109-12. PubMed ID: 1320259 [Abstract] [Full Text] [Related]
5. Influences of an analog of the neuropeptide ACTH 4--9 on mentally retarded adults. Walker BB, Sandman CA. Am J Ment Defic; 1979 Jan; 83(4):346-52. PubMed ID: 217271 [Abstract] [Full Text] [Related]
6. Treatment of panic disorder: nonbenzodiazepine anxiolytics, including buspirone. Robinson DS, Shrotriya RC, Alms DR, Messina M, Andary J. Psychopharmacol Bull; 1989 Jan; 25(1):21-6. PubMed ID: 2570437 [No Abstract] [Full Text] [Related]
7. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer. Roberts JA, Jenison EL, Kim K, Clarke-Pearson D, Langleben A. Gynecol Oncol; 1997 Nov; 67(2):172-7. PubMed ID: 9367703 [Abstract] [Full Text] [Related]
8. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M. J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490 [Abstract] [Full Text] [Related]
9. Treatment of Alzheimer's disease with a synthetic ACTH 4-9 analog. Soininen H, Koskinen T, Helkala EL, Pigache R, Riekkinen PJ. Neurology; 1985 Sep; 35(9):1348-51. PubMed ID: 2991817 [Abstract] [Full Text] [Related]
10. Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain. Beitman BD, Basha IM, Trombka LH, Jayaratna MA, Russell B, Flaker G, Anderson S. J Fam Pract; 1989 Feb; 28(2):177-80. PubMed ID: 2644392 [Abstract] [Full Text] [Related]
16. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders. Pyke RE, Greenberg HS. J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489 [Abstract] [Full Text] [Related]
17. The use of adrenocorticotrophic hormone (4-9) analog ORG 2766 in autistic children: effects on the organization of behavior. Buitelaar JK, van Engeland H, de Kogel KH, de Vries H, van Hooff JA, van Ree JM. Biol Psychiatry; 1992 Jun 01; 31(11):1119-29. PubMed ID: 1326339 [Abstract] [Full Text] [Related]
18. A comparative study of the efficacy of ACTH4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis. Butter HJ, Lapierre Y, Firestone P, Blank A. J Clin Psychopharmacol; 1983 Aug 01; 3(4):226-30. PubMed ID: 6309918 [Abstract] [Full Text] [Related]
19. Psychogenic panic after zidovudine therapy: the therapeutic benefit of an N of 1 trial. Levitt AJ, Lippert GP. CMAJ; 1990 Feb 15; 142(4):341-2. PubMed ID: 2405971 [No Abstract] [Full Text] [Related]